SeaBridge Investment Advisors LLC decreased its stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 4.0% during the fourth quarter, according to the company in its most recent filing with ...

The White House claiming the Wednesday move by the Office of Management and Budget (OMB) rescinding a controversial order ...

Colorado joined the federal government and 38 other states and territories to settle with Pfizer over alleged migraine drug ...

The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...

Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...

Putin is attempting to use the prospect of negotiations to buy time and gain an upper hand in the war in Ukraine, even as he ...

BioAge scrapped the drug at the center of its $198 million initial public offering last year. Elsewhere, Akero and 89bio raised $600 million combined and Allakos laid off staff.

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

Pfizer subsidiary Biohaven allegedly gave physicians speaker honoraria and meals at high-end restaurants to induce them to ...

A Super Bowl ad for weight loss medications from telehealth company Hims & Hers is optimized to engage and infuriate ...

Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to ...

RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of ...